Barrett’s Esophagus: Treatment with 5-Aminolevulinic Acid Photodynamic Therapy - 17/07/18
Doi : 10.1016/S1052-5157(18)30114-4
Hugh Barr, MD, FRCS, FRCSE ⁎
From the Department of Surgery, Cranfield Postgraduate Medical School (Gloucester), Gloucestershire Royal Hospital, Gloucester, United Kingdom
*Address reprint requests to: Hugh Barr, MD, FRCS, FRCSE, Gloucestershire Royal Hospital, Great Western Road, Gloucester, GL1 3NN United KingdomGloucestershire Royal HospitalGreat Western RoadGloucesterGL1 3NNUnited Kingdom
Résumé |
Barrett’s esophagus has been identified as the premalignant precursor of esophageal adenocarcinoma. The eradication of metaplastic or dysplastic columnar-lined (Barrett’s) esophagus may prevent progression to esophageal adenocarcinoma. 5-Aminolevulinic acid photodynamic therapy is a simple method for the mucosal ablation of the abnormal segment. Areas of metaplastic epithelium may remain buried after treatment and continued surveillance is necessary. Repeated treatments often are necessary but are very well tolerated with few complications.
Le texte complet de cet article est disponible en PDF.© 2000
Elsevier Inc. Tous droits réservés.
Vol 10 - N° 3
P. 421-437 - juillet 2000 Retour au numéro
Article précédent
- Photodynamic Therapy of Barrett’s Esophagus
- Kenneth K. Wang
- Photodynamic Therapy of Early Squamous Cell Cancers of the Esophagus
- Alexandre Radu, Georges Wagnières, Hubert van den Bergh, Philippe Monnier
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?